KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹615 Cr | ₹551 Cr | ₹478 Cr | ₹492 Cr | ₹359 Cr |
What is the latest Revenue of KOPRAN ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹615 Cr |
| Mar2024 | ₹551 Cr |
| Mar2023 | ₹478 Cr |
| Mar2022 | ₹492 Cr |
| Mar2021 | ₹359 Cr |
How is Revenue of KOPRAN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹615 Cr | 11.54 | |
| Mar2024 | ₹551 Cr | 15.38 | |
| Mar2023 | ₹478 Cr | -2.91 | |
| Mar2022 | ₹492 Cr | 36.81 | |
| Mar2021 | ₹359 Cr | - | |
Compare Revenue of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹643.4 Cr | -2.2% | -2% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.2% |
-2% |
-23.9% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses